# Trader Brain — October 29, 2026 EOD (paper only)

**Strategy:** `TRADER_BRAIN_PAPER_1000`  
**Status:** ACCOUNTING QUARANTINED; execution and learning disabled  
**Overall process:** D- · **Daily Price Jumps scanner:** F · **Data integrity:** F

## Official accounting and ledger

The sole current episode is `d0eb2031-8dfb-4e1b-b53d-9bb1bd0b90ac`. Its portfolio SHA-256 is `61f213a35147dee89d3ba08e4c7eaa9cbe28143d7cfbf73ddb8e6d53b9dc89a0`, last modified October 26 at 11:30:06 ET. The episode has $1,000 recorded seed cash, no positions, no contemporaneous paper fills, no closed trades, and no weekly lock. The ledger has not been modified to create a trade or fill. **Official October 29 return, P&L and ending equity: UNAVAILABLE**, because a certified 4:00 PM report is missing. Settled cash and buying power are not independently certified. A no-trade day is not automatically a certified 0% return. The legacy $500 exercise ended October 6; retired ledgers are historical only.

| Required ledger field | Current result |
| --- | --- |
| Stock/options entries, exits, partial exits | None recorded |
| Entry timestamp, conviction, Day-Trade Score, price, quantity, stop/T1/T2 | Not applicable: no entry |
| Gross new entry notional, simulated realized P&L | $0.00 / $0.00 |
| Allocated capital, planned new-trade risk | 0% / $0.00 |
| Pre-designated swings, unrealized P&L | None in active episode |
| Official ending equity and return | **Not certified** |

## Research-to-close reconciliation

The immutable canonical **7:00 AM board was not recovered**. A separate Titan market-study file generated at 08:57 ET is not an authorized source for the $1,000 paper strategy.

The saved **9:15 AM checkpoint is contaminated by a retired ledger** (`/Users/harp/.local/state/trader-brain/control-center/portfolio.json`). It quotes $784.03 cash, 78 retired closed trades and overdue XLAB, versus the correct current episode with $1,000 cash and no positions/trades. It also says `retrieved_after_cutoff=true`; its 9:15 candidate observations are reconstructed research, not proven first-seen-at-9:15 discoveries. Its approved paper allocation was zero.

The live runtime produced **195 heartbeats** (07:27–15:58 ET), **11 unique five-minute stock signal/candle observations across SOFI, AAL, ACRS and ABSI**, all ineligible to enter. The 25 repeated raw observations are deduplicated by symbol and candle. The last research batch selected SOFI, AAL, ABNB and ABOS: two symbols had validated historical bars and two were rejected for IEX coverage gaps. The scheduler reported 77 completed batches, 64 resolved equity identities, a 155-minute nominal rotation, no automatic catalog refresh and no market-wide eligible scan. Signals are not fills.

AAL switched from CALL at 15:05 (score 84.21) to PUT at 15:15 (score 78.04), then another PUT at 15:55 (score 91.29). This is **signal instability requiring one-minute-bar, VWAP and new-impulse testing**, not execution alpha. The final heartbeat was at 15:58:13 ET; there was **no certified 4:00 PM closing equity snapshot**.

## Big movers, discovery alpha versus execution alpha

**The 9:15 research was assembled after its cutoff.** Do not credit early discovery without immutable source timestamps. The following are externally reported catalysts and historical research benchmarks, not executed trades.

| Stock | Issuer event | 9:15 reconstruction | Audit |
| --- | --- | --- | --- |
| NCLH | 06:30 beat/raised full-year EBITDA and EPS | +11.30%, $17.874, ~2.61M premarket shares, 0.17% later spread; 79.6% move consumed | A research catalyst; published late-day gain ~13.3%; no verified trade |
| INSM | Strong BRINSUPRI sales and higher drug revenue forecasts | +17.56%, $114.01; later quoted spread 0.44%; 81% consumed | A research catalyst; no entry |
| CROX | Beat and raised guidance | +16.17%, $139.05; later spread ~0.63%; 75% consumed | A catalyst; no validated entry |
| GOOGL | Weak search advertising and AI spending concerns | -11.43%; 97.7% claimed move consumed | Bearish extended gap; no options quote |
| FTNT | Services guidance and decelerating product growth | -26.18%; 93.9% consumed | High extension; no valid short entry |
| NOW | Disappointing cRPO trajectory | -19.84%; 98.1% consumed | Extended gap, subsequently declined further; no paper credit |
| GKOS | Earnings beat and raised sales outlook | +16.08%; later spread 1.75%; 92.1% consumed | Spread risk; no entry |
| **ADT** | **09:20 definitive all-cash buyout for $10/share** | Post-9:15 event, absent from runtime | **Confirmed primary-source coverage miss**, not missed profit |

The nominal 90-day analog samples in the after-cutoff research are only 3–12 events for many names and are **not catalyst-matched**. Decision-time equal-clock RVOL, atomic bid/ask and size, opening-range/VWAP confirmation, genuine remaining move capacity, float/dilution/reverse-split verification and actual executable fill conditions were incomplete. The research's premarket-volume/full-day-average ratios are not valid equal-clock RVOL. Discovery alpha and execution alpha are both **unmeasurable**; all realized paper gain credit is zero.

### Best under-$5 opportunity

**None qualified.** NCPL was the conspicuous raw watch: around $1.6207 and +47.34% on the reconstructed board, with a reported later spread near 1.23%, no verified fresh catalyst, a low remaining-move score and serious historical SEC allegations. It deserved a structural rejection, not a hypothetical entry or profit.

## Capital, risk and cumulative scoreboard

Capital deployed: **$0**, planned new risk: **$0**, observed cash proceeds recycled: none. This was appropriate given execution quarantine. Historical reference risk limits are normal 3%, A+ 4%, maximum aggregate 5%, daily lock 6%, hard kill 8%, weekly lock 12%; their live policy deployment has not been separately certified. No recorded active-episode risk breach.

The active episode remains **zero closed trades, zero wins, zero losses**, with win rate, profit factor, expectancy, maximum drawdown and certified compounded return unavailable or not applicable. Last persisted cash is $1,000, **not certified EOD equity**. The retired earlier episode's 78 closed trades, 13 wins, 65 losses and last indicative -18.567% remain archived, not compounded here; its XLAB paper swing expired without a verified simulated exit and remains unresolved.

## Grades

| Analysis | Discovery | Execution | Allocation | Risk control | Risk-adjusted result | Integrity | Hindsight | Overall |
|---|---|---|---|---|---|---|---|---|
| C- | **F** | N/G | B | B- | N/G | **F** | B+ | **D-** |

## Codex handoff

Preserve **A001–A058** as documented, with all measured effectiveness **INCONCLUSIVE**, no unsupported HELPED/HURT promotions. Continue A054/A055 (canonical certification/source binding), A056 (fresh inventory) and A057 (post-9:15 event interrupt), with no execution permission changes. Add shadow-only **A059**, immutable as-of-cutoff chronology and source binding (30 replay tests, zero false early credits), and **A060**, one-minute/five-minute direction-flip validation (50 shadow signals, 10 flips, 20 provider-fault cases, zero synthetic fills). Neither adjustment is deployed.

**Single top priority:** Fix the canonical 7:00/9:15/desk/16:00 episode binding before any strategy learning or paper entries resume. Next fix market-wide source coverage and prove the 09:20 ADT-type event interrupt. Keep the old XLAB exception archived, never retrospectively close it.

Machine-actionable payload: `knowledge/daily-paper-handoffs/2026-10-29-TRADER_BRAIN_PAPER_1000.json`. Cumulative index: `knowledge/daily-paper-handoffs/2026-10-29-adjustment-registry-summary.json`. Codex ingestion, test execution and deployed fixes are **not confirmed**. Paper only.

## Primary evidence

- Norwegian Cruise Line 06:30 release: https://rss.globenewswire.com/news-release/2026/10/29/3391046/24500/en/norwegian-cruise-line-holdings-reports-third-quarter-2026-financial-results.html
- Insmed earnings: https://investor.insmed.com/2026-10-29-Insmed-Reports-Third-Quarter-2026-Financial-Results-and-Provides-Business-Update
- Crocs earnings: https://investors.crocs.com/news-and-events/press-releases/press-release-details/2026/Crocs-Inc--Reports-Strong-Third-Quarter-2026-Results-Raises-Full-Year-2026-Outlook/default.aspx
- ADT 09:20 acquisition: https://www.nasdaq.com/press-release/adt-be-acquired-thrive-holdings-153-billion-transaction-2026-10-29
- Netcapital prior SEC action: https://www.reuters.com/world/netcapital-charged-by-us-sec-with-fraud-allegedly-inflating-revenue-2026-08-10/
